Detalhe da pesquisa
1.
Analysis of Breast Cancer Mortality in the US-1975 to 2019.
JAMA
; 331(3): 233-241, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227031
2.
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
JAMA
; 331(22): 1947-1960, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687505
3.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029412
4.
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
J Transl Med
; 20(1): 253, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659704
5.
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.
PLoS Comput Biol
; 17(6): e1009020, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34138842
6.
Modeling the natural history of ductal carcinoma in situ based on population data.
Breast Cancer Res
; 22(1): 53, 2020 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32460821
7.
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanoma.
Cancer
; 125(17): 3013-3024, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31067358
8.
Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
J Am Acad Dermatol
; 80(5): 1292-1298, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654075
9.
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
JAMA
; 319(2): 154-164, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318276
10.
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Ann Intern Med
; 164(4): 215-25, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26756606
11.
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials.
Lancet Oncol
; 15(3): 297-304, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24485879
12.
HIV-1 envelope replication and α4ß7 utilization among newly infected subjects and their corresponding heterosexual partners.
Retrovirology
; 10: 162, 2013 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24369910
13.
Distinguishing between CISNET model results versus CISNET models.
Cancer
; 124(5): 1083-1084, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278430
14.
Pediatric melanoma: analysis of an international registry.
Cancer
; 119(22): 4012-9, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24022819
15.
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
Ann Intern Med
; 156(9): 609-17, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547470
16.
Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade.
Cancer Immunol Res
; 11(8): 1100-1113, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37262321
17.
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.
Cancers (Basel)
; 15(9)2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174027
18.
Population simulation modeling of disparities in US breast cancer mortality.
J Natl Cancer Inst Monogr
; 2023(62): 178-187, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947337
19.
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
J Clin Oncol
; 41(2): 186-197, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166727
20.
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
Cancer
; 118(24): 6022-30, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674478